T Stamp Inc: Amended and Restated Bylaws adopted, reducing stockholder meeting quorum from majority to one-third and authorizing Board to designate presiding officer (effective 2022-12-08).
“On December 9, 2022, the Board of Directors of T Stamp, Inc., a Delaware corporation (the "Company"), approved the Amended and Restated Bylaws of the Company (the "Amended Bylaws "). The Amended Bylaws, which was adopted effective as of December 8, 2022, makes the following changes: · Amends Section 1.5 to reduce the number of outstanding shares represented at a meeting of the stockholders from a majority of holders to one-third to constitute a quorum. · Amends Section 1.6 authorize the Board of Directors to designate the officer who will preside over a meeting of the stockholders.”
Auditor Changes
Cherry Bekaert LLP resigned as auditor of T Stamp Inc.
“Resignation of Independent Registered Public Accounting Firm. On December 5, 2022, T Stamp Inc. (the “ Company ”) received its final notification from Cherry Bekaert LLP (“ Cherry Bekaert ”) informing the Company of its resignation, effective that day, as the independent registered public accounting”
Listing & Compliance Notices
T Stamp Inc received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).
“November 15, 2022, T Stamp Inc. (the “Company”) received a notification letter from The Nasdaq Stock Market LLC (“Nasdaq”) informing the Company that, for the last 30 consecutive business days, the bid price of its shares of Class A Common Stock, par value $0.01 per share (the “Common Shares”), had closed below $1.00 per share of Common Stock, which is the minimum required closing bid price for continued listing on Nasdaq pursuant to Listing Rule 5550(a)(2). Under Nasdaq Listing Rule 5810(c)(3)(A), the Company has 180 days, or until May 15, 2023, to regain compliance with the minimum bid price”
Earnings Releases
T Stamp Inc reported for the three months ended September 30, 2022 results: revenue $1.35 million.
“Net revenue increased by $1.02 million or 308.5%, to $1.35 million for Q3 2022, compared to $330 thousand for Q3 2021.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.